A detailed history of Mendota Financial Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Mendota Financial Group, LLC holds 143 shares of LLY stock, worth $106,706. This represents 0.06% of its overall portfolio holdings.

Number of Shares
143
Previous 278 48.56%
Holding current value
$106,706
Previous $252 Million 49.69%
% of portfolio
0.06%
Previous 0.13%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

SELL
$772.14 - $960.02 $104,238 - $129,602
-135 Reduced 48.56%
143 $127 Million
Q1 2024

Apr 25, 2024

SELL
$592.2 - $792.28 $116,071 - $155,286
-196 Reduced 41.35%
278 $216 Million
Q4 2023

Jan 19, 2024

BUY
$525.19 - $619.13 $248,940 - $293,467
474 New
474 $276 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $709B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Mendota Financial Group, LLC Portfolio

Follow Mendota Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mendota Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mendota Financial Group, LLC with notifications on news.